Compare REZI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REZI | RGEN |
|---|---|---|
| Founded | 2018 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.6B |
| IPO Year | 2018 | 1995 |
| Metric | REZI | RGEN |
|---|---|---|
| Price | $39.91 | $123.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 12 |
| Target Price | $39.67 | ★ $167.67 |
| AVG Volume (30 Days) | ★ 1.1M | 999.5K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | N/A | ★ 0.15 |
| Revenue | ★ $7,472,000,000.00 | $141,236,000.00 |
| Revenue This Year | $6.81 | $14.30 |
| Revenue Next Year | $3.62 | $14.52 |
| P/E Ratio | ★ N/A | $840.47 |
| Revenue Growth | 10.52 | ★ 35.10 |
| 52 Week Low | $19.65 | $109.50 |
| 52 Week High | $45.29 | $175.77 |
| Indicator | REZI | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 54.66 | 51.76 |
| Support Level | $39.36 | $121.25 |
| Resistance Level | $43.30 | $130.12 |
| Average True Range (ATR) | 1.18 | 6.50 |
| MACD | -0.19 | 0.60 |
| Stochastic Oscillator | 32.71 | 43.50 |
Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.